TMEM9: A Potential Drug Target and Biomarker for Understanding Skin Health

Target Name: TMEM9

NCBI ID: G252839

TMEM9

TMEM9: A Potential Drug Target and Biomarker for Understanding Skin Health

The skin is an essential organ that plays a crucial role in maintaining the overall health and well-being of the body. It is the largest organ in the body and is responsible for regulating body temperature, protecting the body from external threats, and participating in various physiological processes. The skin is also home to a variety of biomarkers that can provide valuable information about the health and status of the body. One such biomarker is TMEM9, which is derived from the protein complex known as the dermal papilla-derived protein 4 (DpP4). In this article, we will explore TMEM9 as a potential drug target and biomarker for understanding skin health.

TMEM9: The DpP4 Protein Complex

TMEM9 is a 9-kDa protein that is expressed in various tissues of the body, including the skin, hair, nails, and bones. It is highly conserved and has been identified in various species, including humans, mouse, and various bacteria. TMEM9 is derived from the DpP4 protein complex, which is a multi-protein complex that is involved in the regulation of cell growth, differentiation, and survival. The DpP4 protein complex consists of several subunits, including DpP4, DpP5, DpP6, and DpP7, which are involved in various cellular processes, including cell adhesion, migration, and signaling pathways.

TMEM9 Functions as a Biomarker

TMEM9 has been shown to play a significant role in various physiological processes that are important for skin health. One of the functions of TMEM9 is to regulate the growth and differentiation of skin cells. TMEM9 has been shown to promote the survival and proliferation of skin epithelial cells, which are responsible for maintaining the structure and function of the skin. In addition, TMEM9 has been shown to regulate the migration of skin cells, which is important for the development and maintenance of new skin cells.

TMEM9 is also involved in the regulation of skin inflammation. Chronic skin inflammation can lead to various skin disorders, including atopic dermatitis, psoriasis, and dermatitis. TMEM9 has been shown to play a role in regulating the production of pro-inflammatory cytokines, which are important drivers of skin inflammation.

TMEM9 as a Drug Target

TMEM9 has been shown to be a potential drug target for a variety of skin disorders. One of the reasons for its potential as a drug target is its involvement in various signaling pathways that are involved in skin health. For example, TMEM9 has been shown to be involved in the TGF-β signaling pathway, which is involved in cell growth, differentiation, and survival. In addition, TMEM9 has been shown to be involved in the PDGF signaling pathway, which is involved in cell growth and differentiation.

TMEM9 has also been shown to be involved in the NF-kappa-B signaling pathway, which is involved in inflammation and immune responses. Chronic skin inflammation can be caused by various factors, including genetics, hormonal changes, and environmental factors. TMEM9 has been shown to play a role in regulating the production of pro-inflammatory cytokines, which are important drivers of skin inflammation.

Conclusion

TMEM9 is a protein that is derived from the DpP4 protein complex and has been shown to play a significant role in various physiological processes that are important for skin health. TMEM9 is a potential drug target for a variety of skin disorders due to its involvement in various signaling pathways that are involved in skin health. Further research is needed to fully understand the role of TMEM9 in skin health and to develop effective treatments for skin disorders.

Protein Name: Transmembrane Protein 9

Functions: Transmembrane protein that binds to and facilitates the assembly of lysosomal proton-transporting V-type ATPase (v-ATPase), resulting in enhanced lysosomal acidification and trafficking (PubMed:30374053). By bringing the v-ATPase accessory protein ATP6AP2 and the v-ATPase subunit ATP6V0D1 together, allows v-ATPase complex formation and activation (PubMed:30374053). TMEM9-controlled vesicular acidification induces hyperactivation of Wnt/beta-catenin signaling, involved in development, tissue homeostasis and tissue regeneration, through lysosomal degradation of adenomatous polyposis coli/APC (PubMed:30374053, PubMed:32380568). In the liver, involved in hepatic regeneration (PubMed:32380568)

The "TMEM9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets